Covid-19 Has 5 or 6 Variants of Concern: Johns Hopkins

Covid-19 Has 5 or 6 Variants of Concern: Johns Hopkins

Assessment

Interactive Video

Business, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the identification of new COVID-19 variants and their potential impact on transmission and vaccine efficacy. It highlights the importance of vaccines in providing protection against these variants, despite a slight drop in efficacy. The discussion also covers the potential benefits of combining different vaccines to enhance immunity. Finally, the video addresses vaccine rollout strategies and projections, emphasizing the role of vaccine trackers in adapting to changes in manufacturing capacity and new vaccine introductions.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main concern with the new COVID-19 variants?

They are more visible under a microscope.

They cause different symptoms than older strains.

They have mutations affecting transmission and antibody binding.

They are easier to detect with current tests.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How do recent vaccines perform against new COVID-19 variants?

They are completely ineffective.

They are more effective against new variants.

They maintain some efficacy, though slightly reduced.

They have no effect on new variants.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a potential benefit of combining different vaccine shots?

It eliminates the need for booster shots.

It reduces the number of doses needed.

It could increase the overall efficacy.

It makes vaccines cheaper to produce.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What role do vaccine trackers play in the fight against COVID-19?

They help optimize vaccine rollout strategies.

They track the number of people refusing vaccines.

They provide real-time updates on vaccine side effects.

They predict future virus mutations.

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How might increased manufacturing capacity affect vaccine distribution?

It will slow down the distribution process.

It will have no impact on distribution.

It will accelerate the timeline for achieving population immunity.

It will only benefit certain countries.